This study went on to conduct immunohistochemical analysis to monitor the expressed level of osteocalcin (OSC), a protein among BMPs, in the tissue of the control and each experimental group, in order to examine the effects of AutoBT without OM and type I collagen treatment on bone formation. This evidence concerns the gene CLN5 and ocular melanoma.